Pharma feed

N
Merck & Co., Inc.
Hermannherald· 26 May 2019

Stock With Track Record & Analyst Upside: Merck & Co., Inc. (NYSE:MRK)

Shares of Merck & Co., Inc. (NYSE:MRK) have been experiencing an accelerated earnings and sales growth over the past 5 years. Over that time frame the firm has seen earnings growth of 9.60% and sales growth of -0.80%.

  • Merck & Co., Inc.
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Nbonews· 25 May 2019

Merck & Co (MRK) Holder John G Ullman & Associates Has Decreased Its Position by $4.06 Million; Tower Bridge Advisors Has Raised Its Stake in Honeywell Intl (HON) as Shares Rose

Tower Bridge Advisors increased its stake in Honeywell Intl Inc (HON) by 8.46% based on its latest 2018Q4 regulatory filing with the SEC. Tower Bridge Advisors bought 648 shares as the company’s stock rose 7.07% with the market.

  • Merck & Co., Inc.
  • Tower Bridge Advisors Inc
  • Funding Activities
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
Enherald· 25 May 2019

Oppenheimer Asset Management Continues to Hold Holding in Activision Blizzard (ATVI); Founders Capital Management Lowered Its Position in Johnson & Johnson (JNJ) as Market Valuation Declined

Founders Capital Management Llc decreased its stake in Johnson & Johnson (JNJ) by 11.37% based on its latest 2018Q4 regulatory filing with the SEC. Founders Capital Management Llc sold 3,643 shares as the company’s stock declined 5.44% while stock markets rallied.

  • Johnson & Johnson
  • Activision Blizzard, Inc.
  • Asset Management Group
  • New Offerings
  • News Articles
  • News and Other Websites
Verily Life Sciences
Verily· 25 May 2019

Sanofi to collaborate with Google Life Sciences to improve diabetes health outcomes

This insight has a PDF attached. Please click on the headline to view the PDF in a new tab

  • Verily Life Sciences
  • Sanofi
  • Partnerships and Alliances
  • Press Releases
  • Company Websites
Pfizer Inc.
Verily· 25 May 2019

Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research...

This insight has a PDF attached. Please click on the headline to view the PDF in a new tab

  • Pfizer Inc.
  • Verily Life Sciences
  • Novartis AG
  • Sanofi
  • Partnerships and Alliances
  • Press Releases
  • Company Websites
N
Novartis AG
Sky· 25 May 2019

US regulators approve world's most expensive drug - costing £1.6m

The price of Novartis' new drug has provoked criticism Swiss pharmaceutical giant Novartis has won approval for a new gene therapy drug which is priced at a record £1.67m per treatment. Named Zolgensma, the drug has been approved by US regulators for treating babies with spinal muscular atrophy (SMA) - a rare and often fatal disease.

  • Novartis AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Industrynewstoday· 25 May 2019

Global Typhoid Vaccine Market Insights & Depth Analysis: Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical – Industry News Today

The “Typhoid Vaccine Market” report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Typhoid Vaccine market. The report demonstrates a straightforward outline of the Typhoid Vaccine market, that incorporates applications, blueprints, industry chain structure, and definitions.

  • GlaxoSmithKline PLC
  • PaxVax Corp
  • Merck & Co., Inc.
  • Sanofi
  • New Offerings
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Nbonews· 25 May 2019

Stonebridge Capital Management Holding in Merck & Company (MRK) Has Cut as Market Valuation Rose; As Renaissancere Holdings LTD (RNR) Market Value Rose, Shareholder Arga Investment Management LP Cut P

Arga Investment Management Lp decreased its stake in Renaissancere Holdings Ltd (RNR) by 52.93% based on its latest 2018Q4 regulatory filing with the SEC. Arga Investment Management Lp sold 249,575 shares as the company’s stock rose 11.40% with the market.

  • RenaissanceRe Holdings Ltd
  • Stonebridge Capital Management
  • Merck & Co., Inc.
  • ARGA Investment Management LP
  • Procurement and Sales
  • News Articles
  • News and Other Websites
N
NVIDIA Corporation
Enherald· 25 May 2019

Nvidia (NVDA) Holder Dock Street Asset Management Boosted Stake; Merck & Co (MRK) Holding Held by Duncker Streett & Company Inc

Dock Street Asset Management Inc increased its stake in Nvidia (NVDA) by 10.26% based on its latest 2018Q4 regulatory filing with the SEC. Dock Street Asset Management Inc bought 8,608 shares as the company’s stock declined 2.06% while stock markets rallied.

  • Dock Street Asset Management Inc
  • NVIDIA Corporation
  • Merck & Co., Inc.
  • Duncker Streett & Co LLC
  • Procurement and Sales
  • New Offerings
  • News Articles
  • News and Other Websites
N
Verisk Analytics Inc
Cryptocoinstribune· 25 May 2019

First Personal Financial Services Has Raised Its Merck & Co (MRK) Stake by $378,024; Market Value Rose; Loews Decreased Verisk Analytics (VRSK) Stake by $2.73 Million as Stock Price Rose

Loews Corp decreased its stake in Verisk Analytics Inc (VRSK) by 33.33% based on its latest 2018Q4 regulatory filing with the SEC. Loews Corp sold 25,000 shares as the company’s stock rose 1.70% with the market.

  • Verisk Analytics Inc
  • Merck & Co., Inc.
  • First Personal Financial Corp
  • Funding Activities
  • News Articles
  • News and Other Websites
N
Regeneron Pharmaceuticals Inc
Nbonews· 25 May 2019

Regeneron Pharmaceuticals (REGN) Shareholder Texas Permanent School Fund Cut Position as Market Value Rose; Horan Capital Management Stake in Microsoft (MSFT) Increased as Valuation Rose

Horan Capital Management increased its stake in Microsoft Corp (MSFT) by 1.96% based on its latest 2018Q4 regulatory filing with the SEC. Horan Capital Management bought 5,371 shares as the company’s stock rose 1.03% with the market.

  • Regeneron Pharmaceuticals Inc
  • Horan Capital Management LLC
  • Funding Activities
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Nbonews· 25 May 2019

Merck & Co (MRK) Market Value Rose While Terril Brothers Cut by $946,580 Its Position; As Us Bancorp (USB) Stock Value Declined, Bartlett & Co Has Lowered Its Position by $424,575

Bartlett & Co decreased its stake in Us Bancorp (USB) by 0.71% based on its latest 2018Q4 regulatory filing with the SEC. Bartlett & Co sold 9,435 shares as the company’s stock declined 4.83% while stock markets rallied.

  • Merck & Co., Inc.
  • Procurement and Sales
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Nbonews· 25 May 2019

Cullen Capital Management Holding in Merck & Co. (MRK) Has Cut by $7.37 Million as Market Valuation Rose; As Suncoke Energy (SXC) Valuation Rose, Gendell Jeffrey L Raised Holding

Gendell Jeffrey L increased its stake in Suncoke Energy Inc (SXC) by 6.23% based on its latest 2018Q4 regulatory filing with the SEC. Gendell Jeffrey L bought 54,912 shares as the company’s stock rose 1.13% with the market.

  • Merck & Co., Inc.
  • SunCoke Energy Inc
  • Funding Activities
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Driscoll Register· 25 May 2019

Merck Tbk (MERK.JK) Shares Drop -5.44% – Driscoll Register

Merck Tbk (MERK.JK) has ended the quarter in the red, yielding negative results for the shares at they ticked -5.44% over that time frame. In taking a look at recent performance, we can see that shares have moved 0.00% over the past 4-weeks, 14.73% over the past half year and -7.27% over the past full year.

  • Merck & Co., Inc.
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Pfizer Inc.
AsianCrunch· 25 May 2019

Global Hospital Acquired Infection Control Market Study 2019-2025: Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD – AsianCrunch

The “Hospital Acquired Infection Control market” report offers an influential source to assess the Hospital Acquired Infection Control market and back the preemptive and strategic decision-making. It entails the straightforward statistics and comprehensive scurrility of the market.

  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Amgen, Inc.
Enherald· 25 May 2019

Costco Whsl New (COST) Shareholder Comgest Global Investors Sas Cut Its Position by $1.26 Million; Amgen (AMGN) Stake Has Raised by Ledyard National Bank

Ledyard National Bank increased its stake in Amgen Inc (AMGN) by 5.58% based on its latest 2018Q4 regulatory filing with the SEC. Ledyard National Bank bought 1,998 shares as the company’s stock declined 5.78% while stock markets rallied.

  • Amgen, Inc.
  • Ledyard National Bank
  • Funding Activities
  • News Articles
  • News and Other Websites
Johnson & Johnson
Johnson & Johnson· 25 May 2019

Johnson & Johnson Announces Definitive Agreement To Collaborate With Google To Advance Surgical Robotics

Corporate Share Strategic Collaboration Designed to Develop New Technologies that Offer Surgeons and Health Care Systems Greater Accuracy, Cost Efficiency and Better Outcomes for Patients NEW BRUNSWICK, N.J.

  • Johnson & Johnson
  • Partnerships and Alliances
  • Press Releases
  • Company Websites
N
Pfizer Inc.
Industry Reports· 25 May 2019

Global Statin Market Competitive Situation and Trends 2019-2025 Merck, Pfizer, Amgen. – Industry Reports

The QY Market Study gives the brief research report of the Statin Market around the globe. The study of reports gives always satisfactory solution to the user. The research study includes analysis, forecast and revenue of the market from 2019 to 2025.

  • Pfizer Inc.
  • Merck & Co., Inc.
  • Amgen, Inc.
  • Competitive Landscape
  • News Articles
  • News and Other Websites
N
Mylan Specialty LP
Worldwide Market· 25 May 2019

Hospital-Acquired Pneumonia Drugs Market Production Growth Rate 2019-2025 Merck, Mylan, Novartis. – Worldwide Market

A market study on the “Global Hospital-Acquired Pneumonia (HAP) Drugs Market Research Report 2019-2025″” By QYMarketStudy. It analyses the important factors of the Hospital-Acquired Pneumonia (HAP) Drugs market based on present market situations, demands, business strategies utilized by Hospital-Acquired Pneumonia (HAP) Drugs market players and the future prospects from various angles in detail.

  • Mylan Specialty LP
  • Merck & Co., Inc.
  • Novartis AG
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Hermannherald· 25 May 2019

Quant Data & Earnings in Focus For Roku, Inc. (NasdaqGS:ROKU), Merck & Co., Inc. (NYSE:MRK)

In taking a look at some key indicators for Roku, Inc. (NasdaqGS:ROKU), we note that the current Book to Market value for the firm is at 0.035367. The Book to Market or BTM is calculated as Market Value (or Stock Price)/Book Value.

  • Focus Group
  • Merck & Co., Inc.
  • Roku Inc
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Regeneron Pharmaceuticals Inc
Cryptocoinstribune· 25 May 2019

Reviewing Regeneron Pharmaceuticals Inc. (REGN)’s and Rafael Holdings Inc. (NYSEAMERICAN:RFL)’s results

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Rafael Holdings Inc. (NYSEAMERICAN:RFL) compete against each other in the Biotechnology sector. We will compare them and contrast their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Regeneron Pharmaceuticals Inc.

  • Regeneron Pharmaceuticals Inc
  • Rafael Holdings, Inc.
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Florence Standard· 25 May 2019

Can Merck Limited (MERCK.NS) Continue to Move Higher? Shares Climb 18.13% For the Quarter – Florence Standard

Merck Limited (MERCK.NS) has ended the quarter in the black, yielding positive results for the shares at they ticked 18.13% tracking back thirteen weeks ago. In taking a look at recent performance, we can see that shares have moved 2.82% over the past 4-weeks, 31.62% over the past half year and 82.01% over the past full year.

  • Merck & Co., Inc.
  • Financial and Business Performance
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Free Press Journal· 25 May 2019

GSK, Pfizer consumer healthcare joint venture formation approved

New Delhi: The Competition Commission (CCI) said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer. GSK, in December 2018, had said it has reached an agreement with Pfizer to combine their consumer health businesses into a new joint venture (JV) with combined sales of around USD 12.7 billion (around Rs 88,900 crore).

  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Downeygazette· 25 May 2019

Global Hospital-Acquired Infection Control Market, Top Player like AstraZeneca, GlaxoSmithKline, Merck, Growth Opportunities will reach CAGR of 4.81% in 2023

Global Hospital-Acquired Infection Control Market Report gives the present situation and the growth projections of the business for 2018-2023 period. The information helps in computing the market size, the report considers the revenue generated from the sales worldwide.

  • GlaxoSmithKline PLC
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Opportunities, Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
The Economic Times· 25 May 2019

CCI approves GSK, Pfizer joint venture in consumer healthcare

New Delhi: The Competition Commission of India (CCI) has approved a joint venture by pharmaceuticals companies GlaxoSmithKline and Pfizer in the consumer healthcare market. GSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies’ consumer healthcare businesses.

  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • CCI Corporation
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
1 2 3 4 5